Holen Sie sich die Stockscreener-App
15.54
4.90%
-0.80
Handel nachbörslich:
15.66
0.12
+0.77%
Wave Life Sciences Ltd Aktie (WVE) Neueste Nachrichten
Wave Life Sciences (WVE) Stock News Today (Dec. 18, 2025): Why Shares Are Sliding, New Analyst Targets, and the Next Catalysts After WVE-007 Obesity Data - ts2.tech
WAVE Life Sciences (NASDAQ:WVE) Shares Down 4.3%Here's Why - MarketBeat
CEO Moves: Is Wave Life Sciences Ltd stock supported by innovation pipeline2025 Market Trends & Step-by-Step Trade Execution Guides - moha.gov.vn
Wave Life Sciences (WVE) Is Down 19.2% After $350 Million Equity Raise On Obesity DataWhat's Changed - simplywall.st
Wave Life Sciences drops after trial data for GSK-partnered RNA-editing therapy - MSN
Share Offerings Prompt Huge Insider Buying in These 3 Biotechs - AOL.com
United StatesMintz Advises On Wave Life Sciences $402.5 Million Public Offering - Mondaq
Oppenheimer Maintains Wave Life Sciences (WVE) Outperform Recommendation - Nasdaq
Oppenheimer raises WAVE Life Sciences stock price target to $32 on WVE-007 data By Investing.com - Investing.com South Africa
Best Biotech Stocks To Keep An Eye OnDecember 8th - MarketBeat
WAVE Life Sciences (NASDAQ:WVE) Shares Gap Up Following Insider Buying Activity - MarketBeat
Oppenheimer Raises Price Target for WAVE Life Sciences (WVE) | WVE Stock News - GuruFocus
Wave Life Sciences (WVE) Stock News Today: Oppenheimer Lifts Target to $32 as WVE-007 Obesity Data Fuels Volatility - ts2.tech
Wave Life (WVE) shares nearly triple on encouraging obesity drug trial - MSN
Subdued Growth No Barrier To Wave Life Sciences Ltd. (NASDAQ:WVE) With Shares Advancing 128% - simplywall.st
Oppenheimer raises WAVE Life Sciences stock price target to $32 on WVE-007 data - Investing.com India
Obesity data, Kymera and FDA sentiment survey results — a BioCentury podcast - BioCentury
WAVE Life Sciences (NASDAQ:WVE) Major Shareholder Purchases 1,470,000 Shares - MarketBeat
Wave Life Sciences’ Obesity Drug Draws $10 Billion Expectations - Finimize
Wave Life Sciences' Obesity Drug Shows Promise for Long-Term Growth, Truist Says - marketscreener.com
Truist Securities Maintains Wave Life Sciences (WVE) Buy Recommendation - Nasdaq
Truist Securities Elevates WAVE Life Sciences (WVE) Price Target to $50 | WVE Stock News - GuruFocus
WAVE Life Sciences stock price target raised to $50 from $36 at Truist - Investing.com India
Truist Raises Price Target on Wave Life Sciences to $50 From $36, Keeps Buy Rating - marketscreener.com
Why Did Wave Life Sciences Surge 147%? - Forbes
Wave Life (WVE) Shares Nearly Triple on Encouraging Obesity Drug Trial - Insider Monkey
Medical Stocks To Watch TodayDecember 8th - MarketBeat
WAVE Life Sciences Ltd. $WVE Position Raised by 683 Capital Management LLC - MarketBeat
WAVE Life Sciences (NASDAQ:WVE) Raised to Hold at Wall Street Zen - MarketBeat
B. Riley Securities Maintains Wave Life Sciences (WVE) Buy Recommendation - Nasdaq
WAVE Life Sciences (NASDAQ:WVE) Sees Strong Trading VolumeShould You Buy? - MarketBeat
WAVE Life Sciences (NASDAQ:WVE) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Wedbush Maintains Wave Life Sciences (WVE) Outperform Recommendation - Nasdaq
WVE: B. Riley Securities Raises Price Target Amid Positive Outlo - GuruFocus
Wave Life Sciences' Robust 2026 Pipeline to Support Outlook, Wedbush Says - marketscreener.com
B. Riley Adjusts Price Target on Wave Life Sciences to $37 From $19, Maintains Buy Rating - marketscreener.com
WVE Stock Receives Analyst Rating Update from Wedbush | WVE Stoc - GuruFocus
Wedbush raises WAVE Life Sciences stock price target to $33 on obesity data - Investing.com India
Wave Life Sciences (WVE) Sees Price Target Boost to $33 by Wedbu - GuruFocus
Wedbush Raises Price Target on Wave Life Sciences to $33 From $20, Adds to Best Ideas List, Keeps Outperform Rating - marketscreener.com
Jefferies reiterates buy rating on WAVE Life Sciences stock amid recent pressure - Investing.com India
WAVE Life Sciences (NASDAQ:WVE) CFO Kyle Moran Sells 50,036 Shares - MarketBeat
Insider Selling: WAVE Life Sciences (NASDAQ:WVE) CFO Sells 210,000 Shares of Stock - MarketBeat
Insider Selling: WAVE Life Sciences (NASDAQ:WVE) Director Sells 14,000 Shares of Stock - MarketBeat
Wave Life Sciences (WVE) Stock on December 11, 2025: Obesity Breakthrough, 180% Rally, $350M Offering and Fresh Analyst Targets - ts2.tech
Wave Life Sciences prices upsized $350M stock offering - MSN
Wave Life Science prices upsized $350M stock ofeering - MSN
Wave Life Sciences (WVE) Stock Faces Sharp Decline - GuruFocus
Wave Life Sciences (WVE) Stock Experiences Decline - GuruFocus
WVE Shares Dip After Secondary Offering and Market Reaction - timothysykes.com
WVE Stock Surges More Than 180% in a Week: What Is Driving This Rally? - Nasdaq
Wave Life Sciences director Henry sells shares for $1.36 million By Investing.com - Investing.com Canada
Wave Life Sciences (WVE) soars to 6-year high on obesity drug clinical trial - MSN
Corrigan sells Wave Life Sciences (WVE) shares worth $217k By Investing.com - Investing.com Nigeria
Golden Cross Alert: 3 Stocks With Major Upside Potential - Investing.com
Wave Life Sciences (WVE) CFO Moran sells shares worth $4.1 million By Investing.com - Investing.com Canada
Wave Life Sciences (WVE) CFO Moran sells shares worth $4.1 million - Investing.com Nigeria
Corrigan sells Wave Life Sciences (WVE) shares worth $217k - Investing.com
Wave Life Sciences director Wagner sells $189,000 in shares By Investing.com - Investing.com Nigeria
Tan Aik Na of Wave Life Sciences sells $1.82 million in stock - Investing.com Nigeria
Wave Life Sciences exec Francis sells $6.4m in shares - Investing.com India
Verdine of Wave Life Sciences sells shares worth $269k - Investing.com India
0.31%
0.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):